Aberrant Drug-Related Behavior Observed During a 12-Week Open-Label Extension Period of a Study Involving Patients Taking Chronic Opioid Therapy for Persistent Pain and Fentanyl Buccal Tablet or Traditional Short-Acting Opioid for Breakthrough Pain.
Saved in:
| Title: | Aberrant Drug-Related Behavior Observed During a 12-Week Open-Label Extension Period of a Study Involving Patients Taking Chronic Opioid Therapy for Persistent Pain and Fentanyl Buccal Tablet or Traditional Short-Acting Opioid for Breakthrough Pain. |
|---|---|
| Authors: | Passik, Steven D.1, Narayana, Arvind2, Yang, Ronghua2 |
| Source: | Pain Medicine. Aug2014, Vol. 15 Issue 8, p1365-1372. |
| Database: | SPORTDiscus with Full Text |
| ISSN: | 15262375 |
|---|---|
| DOI: | 10.1111/pme.12431 |
